This site is intended for Healthcare professionals only.

High-Dose Aspirin Preferred in Kawasaki disease


High-Dose Aspirin Preferred in Kawasaki disease

Dr. Anita Dhanrajani and associates reviewed charts of patients with Kawasaki disease (KD) from two Canadian centres to assess the impact of ASA dose on IVIG resistance (operationally defined as administration of a second dose of IVIG). Both centres used standard IVIG dosing, but centre 1 used low-dose ASA from diagnosis (3-5 mg/kg/day) while centre 2 used initial high-dose ASA (80-100 mg/kg/day). The researchers found that high dose of Aspirin decreased probability of IVIG re-treatment in Kawasaki disease.

Kawasaki disease (KD) is an acute childhood vasculitis that may result in coronary aneurysms. Treatment of Kawasaki disease (KD) with a single infusion of 2g/kg intravenous immunoglobulin (IVIG) is well established, but acetyl-salicylic acid (ASA) dose remains controversial.

In one hospital where low-dose acetylsalicylic acid (ASA; 3 to 5 mg/kg/day) was routinely used, 23% of patients were given a second infusion of IVIG, compared with 8.7% of those treated in another hospital where high-dose ASA (80 to 100 mg/kg/day) was used (P=0.003), according to Anita Dhanrajani, MBBS, of British Columbia Children’s Hospital in Vancouver, and colleagues.

It was found that there were no significant differences in baseline characteristics between the two centres. Re-treatment with a second dose of IVIG was required in 28/122 (23%) patients treated with low-dose ASA, and in 11/127 (8.7%) patients treated with high-dose ASA (p=0.003). After adjusting for confounders, low-dose ASA was associated with higher odds of IVIG resistance (OR=3.2, 95% CI 1.1, 9.1). The mean duration of hospital stay was 4.1 and 4.7 days, respectively (p= 0.37). Coronary artery aneurysms were seen in 2/117 and 6/125 patients from centre 1 and 2, respectively (p= 0.28).

The authors concluded that low-dose ASA was associated with 3 times higher odds of IVIG re-treatment compared to high-dose ASA, with no significant difference in duration of hospital stay or incidence of coronary artery aneurysms.

The research findings were reported online in Arthritis Care & Research.

The following two tabs change content below.
Anjali Nimesh

Anjali Nimesh

Anjali Nimesh Joined Medical Dialogue as Reporter in 2016. she covers all the medical specialty news in different medical categories. She also covers the Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in medical filed. She is a graduate from Dr. Bhimrao Ambedkar University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Source: self

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted